MCWS
ANIP icon

McKinley Carter Wealth Services’s ANI Pharmaceuticals ANIP Stock Holding History

McKinley Carter Wealth Services’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-650
Closed -$38K – 168
2018
Q1 		$38K Buy
+650
New +$41.3K 0.01% 287

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

McKinley Carter Wealth Services's ANIP Position: Q2 2018 in Review

McKinley Carter Wealth Services sold out of ANI Pharmaceuticals (ANIP) in Q2 2018, closing a stake of 650 shares — an estimated $38K sold.

McKinley Carter Wealth Services first reported a position in ANIP in Q1 2018 and held it in 1 quarter. The position peaked at $38K in Q1 2018. 184 funds tracked by Wall St. Rank hold ANIP as of Q2 2018.

  • McKinley Carter Wealth Services reported no remaining ANI Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • McKinley Carter Wealth Services sold 650 ANI Pharmaceuticals shares in Q2 2018, an estimated $38K.
  • McKinley Carter Wealth Services first reported a position in ANI Pharmaceuticals in Q1 2018 and held it in 1 quarter.
  • McKinley Carter Wealth Services's ANI Pharmaceuticals position peaked at $38K in Q1 2018.
  • 184 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2018.

Based on McKinley Carter Wealth Services's 13F filing for Q2 2018, filed 7 Dec 2018.